Cargando…

Cannabidiol: potential in treatment of neurological diseases, flax as a possible natural source of cannabidiol

Detalles Bibliográficos
Autor principal:	Storozhuk, Maksim V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cellular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150377/ https://www.ncbi.nlm.nih.gov/pubmed/37138768 http://dx.doi.org/10.3389/fncel.2023.1131653

Ejemplares similares

Cannabidiol Is a Novel Modulator of Bacterial Membrane Vesicles
por: Kosgodage, Uchini S., et al.
Publicado: (2019)

The antimicrobial potential of cannabidiol
por: Blaskovich, Mark A. T., et al.
Publicado: (2021)

Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease
por: Silvestro, Serena, et al.
Publicado: (2020)

Cannabidiol as a potential treatment for psychosis
por: Davies, Cathy, et al.
Publicado: (2019)

Potential of Cannabidiol for the Treatment of Viral Hepatitis
por: Lowe, Henry I. C., et al.
Publicado: (2017)

Cannabidiol to Improve Mobility in People with Multiple Sclerosis
por: Rudroff, Thorsten, et al.
Publicado: (2018)

Cannabidiol activates neuronal Kv7 channels
por: Zhang, Han-Xiong Bear, et al.
Publicado: (2022)

Cannabidiol in the Treatment of Epilepsy
por: von Wrede, Randi, et al.
Publicado: (2021)

Cannabidiol in Parkinson’s disease
por: Rieder, Carlos R.
Publicado: (2020)

The therapeutic potential of purified cannabidiol
por: O’Sullivan, Saoirse Elizabeth, et al.
Publicado: (2023)

Cannabidiol and mental health: possibilities, uncertainties, and controversies for addiction treatment
por: Kessler, Felix H., et al.
Publicado: (2021)

Biological bases for a possible effect of cannabidiol in Parkinson’s disease
por: Ferreira-Junior, Nilson C., et al.
Publicado: (2019)

Cannabidiol as a treatment for epilepsy
por: Pickrell, William O., et al.
Publicado: (2017)

Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
por: Singh, Kuldeep, et al.
Publicado: (2023)

Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action
por: Ożarowski, Marcin, et al.
Publicado: (2021)

Cannabidiol sensitizes TRPV2 channels to activation by 2-APB
por: Gochman, Aaron, et al.
Publicado: (2023)

The potential of cannabidiol in the COVID‐19 pandemic
por: Esposito, Giuseppe, et al.
Publicado: (2020)

Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function
por: Abbotts, Kieran Shay Struebin, et al.
Publicado: (2022)

The Pro-neurogenic Effects of Cannabidiol and Its Potential Therapeutic Implications in Psychiatric Disorders
por: Luján, Miguel Á., et al.
Publicado: (2020)

The gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol
por: Oliveira, Bruna Stefane Alves de, et al.
Publicado: (2022)

Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users
por: Fortin, Davide, et al.
Publicado: (2021)

Cannabidiol Regulates Long Term Potentiation Following Status Epilepticus: Mediation by Calcium Stores and Serotonin
por: Maggio, Nicola, et al.
Publicado: (2018)

The Polypharmacological Effects of Cannabidiol
por: Castillo-Arellano, Jorge, et al.
Publicado: (2023)

Plasma Pharmacokinetics of Cannabidiol Following Oral Administration of Cannabidiol Oil to Dairy Calves
por: Meyer, Kelsey, et al.
Publicado: (2022)

Modulation of cognitive and emotional processing by cannabidiol: the role of the anterior cingulate cortex
por: Kowal, Mikael A., et al.
Publicado: (2013)

Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
por: Raucci, Umberto, et al.
Publicado: (2020)

Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2021)

Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs
por: Garcia, Gabriel A., et al.
Publicado: (2022)

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
por: Morales, Paula, et al.
Publicado: (2017)

The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets
por: Vitale, Rosa Maria, et al.
Publicado: (2021)

Cannabidiol and Other Cannabinoids in Demyelinating Diseases
por: Navarrete, Carmen, et al.
Publicado: (2021)

The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia
por: Visini, Gabriela, et al.
Publicado: (2022)

Cannabidiol's neuroprotective properties and potential treatment of traumatic brain injuries
por: Aychman, Mackenzie M., et al.
Publicado: (2023)

Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration
por: Yau, Grace Tsz Yan, et al.
Publicado: (2023)

Cannabidiol Content and In Vitro Biological Activities of Commercial Cannabidiol Oils and Hemp Seed Oils
por: Kitamura, Masashi, et al.
Publicado: (2020)

Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from Cannabis sativa L.
por: Martinenghi, Laura Daniela, et al.
Publicado: (2020)

Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses
por: Umpierrez, Laísa S., et al.
Publicado: (2022)

Pharmacovigilance on cannabidiol as an antiepileptic agent
por: Ammendolia, Ilaria, et al.
Publicado: (2023)

Cannabidiol in epilepsy: The indications and beyond
por: Ryan, Melody
Publicado: (2020)

Immune Responses Regulated by Cannabidiol
por: Nichols, James M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_etn38ia6detfagdqv74hlstvve